Belantamab mafodotin-containing product in parenteral dose form 896750002
SNOMED CT code
SNOMED code | 896750002 |
---|---|
name | Belantamab mafodotin-containing product in parenteral dose form |
status | active |
date introduced | 2021-01-31 |
fully specified name(s) | Product containing belantamab mafodotin in parenteral dose form (medicinal product form) |
synonyms | Belantamab mafodotin-containing product in parenteral dose form |
attributes - group0 | |
Has manufactured dose form | Parenteral dose form 385287007 |
Plays role | Antineoplastic therapeutic role 773879000 |
attributes - group1 | |
Has active ingredient | Belantamab mafodotin 895362005 |
parents | |
children | Belantamab mafodotin only product in parenteral dose form 896751003 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Belantamab mafodotin-containing product in parenteral dose form 896750002 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by therapeutic role 763087004 Antineoplastic agent 27867009 Monoclonal antibody antineoplastic agent 1144210000 Belantamab mafodotin-containing product 896748005 Belantamab mafodotin-containing product in parenteral dose form 896750002 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.